Abiopharma

(99% Neutral) PRAXIS PRECISION MEDICINES, INC. (PRAX) Announces New Board Appointment

(90% Positive) KALVISTA PHARMACEUTICALS, INC. (KALV) Announces Enrollment Update for interest Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(99% Neutral) Quanterix Corp (QTRX) Announces Clinical Development Update

QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

📋 Golden Lee Scott (Officer) plans to sell 866 shares of PTC THERAPEUTICS, INC. (at $76.45 each, total $66K) Filed: Jan 08, 2026 | ID: 000231

Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments

PAKOLA STEVE 🟢 acquired 101.2K shares (1 derivative) of REGENXBIO Inc. (RGNX) at $14.18 Transaction Date: Jan 06, 2026 | Filing ID: 000004

Malzahn Craig 🟢 acquired 101.2K shares (1 derivative) of REGENXBIO Inc. (RGNX) at $14.18 Transaction Date: Jan 06, 2026 | Filing ID: 000003

📋 Indig Chaim (Officer) plans to sell 8K shares of Phreesia, Inc. (at $17.01 each, total $144K) Filed: Jan 08, 2026 | ID: 000230

Simpson Curran 🟢 acquired 378.5K shares (1 derivative) of REGENXBIO Inc. (RGNX) at $14.18 ($3.3M) Transaction Date: Jan 06, 2026 | Filing ID: 000004

📋 Kintz Samuel (Officer) plans to sell 82K shares of Enliven Therapeutics, Inc. (at $15.47 each, total $1.3M) Filed: Jan 08, 2026 | ID: 000006

Christmas Patrick J. 🟢 acquired 113.4K shares (1 derivative) of REGENXBIO Inc. (RGNX) at $14.18 Transaction Date: Jan 06, 2026 | Filing ID: 000004

(70% Positive) Illumina, Inc. (ILMN) Files Form 8-K

📋 Pauwels Eric (Officer) plans to sell 3K shares of PTC THERAPEUTICS, INC. (at $76.53 each, total $241K) Filed: Jan 08, 2026 | ID: 000228

📋 Klein Matthew B. (Officer) plans to sell 3K shares of PTC THERAPEUTICS, INC. (at $76.45 each, total $192K) Filed: Jan 08, 2026 | ID: 000227